Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsMind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Sneha Mantri, MD, MS. [LISTEN TIME: 24 minutes]
Inebilizumab is the first CD19-targeted B-cell therapy approved for antiAChR- or antiMuSK antibody–positive generalized myasthenia gravis, providing symptom control with twice-yearly dosing.
Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome
1.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
2.
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
3.
Inadvertent lung cancer screening results are discussed in a new study.
4.
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
5.
Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer
1.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
2.
Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology
3.
New Anticoagulants: Balancing Efficacy and Safety in Patients with Atrial Fibrillation
4.
AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology
5.
Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge